1.
Khanmohammadi S, Habibzadeh A, Kamrul-Hasan ABM, Schuermans A, Kuchay MS. Glucose-lowering drugs and liver-related outcomes among individuals with type 2 diabetes: A systematic review of longitudinal population-based studies. Diabetic medicine : a journal of the British Diabetic Association. 2024:e15437. doi:10.1111/dme.15437.
1.
Oren O, Natarajan P, Bhatt DL. SGLT2 Inhibitors in Patients With Cancer Therapy-Related Cardiotoxicity: An Unexpected Benefit?. JACC. Heart failure. 2024;12(1):79-82. doi:10.1016/j.jchf.2023.10.005.